PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, presenting promising breakthroughs throughout many health care and industrial apps. With its structural similarity to The natural way derived human serum albumin, OsrHSA delivers a safer, more reliable alternative for therapeutic use,